Our IHC experiment also showed that higher CCDC50 expression is significantly associated with shorter overall survival time in DLBCL (p < 0.0001, Fig. 1I, Supplementary file 3). The gene discussed is CCDC50; the disease is diffuse large B-cell lymphoma.